Literature DB >> 2738262

Balloon dilation of pulmonary venous pathway obstruction after Mustard repair for transposition of the great arteries.

S G Cooper1, I D Sullivan, C Bull, J F Taylor.   

Abstract

Percutaneous balloon dilation was attempted in three patients with mid baffle pulmonary venous pathway obstruction after the Mustard operation for transposition of the great arteries. The procedure was unsuccessful in a 3 year old boy. Evidence for relief of obstruction in the other two patients (7 and 14 years old, respectively) consisted of angiographic demonstration of improved caliber at the site of the pulmonary venous pathway narrowing, improvement in the Doppler spectral signal at this site from an "obstructed" to a "normal" pattern as well as symptomatic improvement. Balloon dilation was performed twice in one of these patients. The Doppler and symptomatic improvement were sustained in both patients at short-term follow-up (5 and 6 months, respectively). This technique may offer effective relief of pulmonary venous pathway obstruction in some patients with this complication of the Mustard operation.

Entities:  

Mesh:

Year:  1989        PMID: 2738262     DOI: 10.1016/0735-1097(89)90072-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  3 in total

1.  Pulmonary venous atrial obstruction after the Senning procedure: relief by catheter balloon dilatation.

Authors:  J D Coulson; R B Jennings; D H Johnson
Journal:  Br Heart J       Date:  1990-08

2.  Endovascular stent placement for pulmonary venous obstruction after Mustard operation for transposition of the great arteries.

Authors:  J M Abdulhamed; S A Alyousef; C Mullins
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

3.  Stenting of superior vena cava and inferior vena cava for symptomatic narrowing after repeated atrial surgery for D-transposition of the great vessels.

Authors:  P Chatelain; B Meier; B Friedli
Journal:  Br Heart J       Date:  1991-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.